Row flares over global fight against fake medicine

LONDON Wed Nov 14, 2012 5:16am IST

Counterfeit drugs seized by the U.S. Customs & Border Protection are seen on display at the agency's offices at John F. Kennedy Airport in New York August 15, 2012. REUTERS/Keith Bedford

Counterfeit drugs seized by the U.S. Customs & Border Protection are seen on display at the agency's offices at John F. Kennedy Airport in New York August 15, 2012.

Credit: Reuters/Keith Bedford

Related Topics

Stocks

   
Priyanka Gandhi Vadra, daughter of Congress party chief Sonia Gandhi, adjusts her flower garlands as she campaigns for her mother during an election meeting at Rae Bareli in Uttar Pradesh April 22, 2014. REUTERS/Pawan Kumar

Election 2014

More than 814 million people — a number larger than the population of Europe — are eligible to vote in the world’s biggest democratic exercise.  Full Coverage 

LONDON (Reuters) - A group of experts calling for a global treaty to stop the lethal trade in fake medicines has been barred from attending a World Health Organisation meeting, highlighting deep divisions that are blocking progress on the subject.

Leading academics and health professionals hoped to provoke debate on the need for a new international law to prevent falsified and substandard drugs reaching the market with a paper published in the British Medical Journal on Wednesday.

Their article, which sets out a clear case for a fake drugs treaty similar to existing ones on money laundering and human trafficking, comes a week before 100 states hold the first meeting of its kind to discuss the problem in Buenos Aires.

But lead author Amir Attaran of the University of Ottawa said he was told on Monday by the World Health Organisation (WHO) that he and other non-governmental representatives could not attend, following an objection by India.

A WHO spokeswoman declined to comment on the details of particular invitations but said it was up to member states to determine who was permitted to attend. Indian officials, whose government is wary of multinational drug firms using the issue to curb competition, were not immediately available for comment.

Attaran called it a "scandal" that only government officials would be at the meeting in Argentina to discuss strategy.

The clash exposes distrust among governments, the pharmaceutical industry and healthcare campaigners about how to tackle fake and dangerous medicines, which are a growing problem in both poor countries and rich. Risks include ineffective material packaged as medication and real drugs made in poor conditions.

In developing countries, the WHO estimates that more than 10 percent of medicine may be fake or substandard, with bogus malaria drugs a particular threat in parts of Asia and Africa.

But the danger is real in the rich world, too.

Earlier this year, fake vials of Roche's cancer drug Avastin were found in the United States, while a recent U.S. meningitis outbreak, due to contaminated steroid injections, shows the country is not immune to quality problems.

In the European Union, medicines are now the top illicit product seized at the border and authorities have found fake versions of drugs purporting to come from companies including Sanofi, Eli Lilly and AstraZeneca.

LAW TOUGHER ON TOBACCO THAN FAKE DRUGS

The need for action seems clear enough - but advancing the debate involves navigating some big divides.

India, whose large drugs industry produces cheap generic versions, is concerned that Western governments backed by Big Pharma are using the fight against fakes as a cover to restrict trade in unpatented medicines much needed by the world's poor.

Some health activists support New Delhi's charge that worries about counterfeit drugs are being hijacked by "Big Pharma" global pharmaceutical companies to protect their profits and patented products against legitimate generic competitors.

In east Africa, for example, international drug companies have taken advantage of anti-counterfeiting laws that are sometimes poorly drafted to curb sales of otherwise legitimate generics, threatening the availability of essential drugs.

India is particularly resistant to any role for pharmaceutical firms in setting the agenda, and Brazil has expressed similar concerns in the past.

Given the distrust, the authors of the paper in the BMJ - who include leaders of nursing, pharmacy and public health bodies - argue there is a need to find neutral ground to address what appears to be a gaping hole in international law.

They point out that thanks to a new convention on tobacco control, international law is now tougher on counterfeit cigarettes than it is on fake medicines.

"We hope that this will form the basis for getting some consensus on a definition of counterfeit drugs, which would then be transferable into a legal instrument," said another of the paper's authors, Martin McKee of the London School of Hygiene and Tropical Medicine.

The lack of a treaty means there is no agreement on which medicines are illegal and criminals can do business in countries where laws or enforcement are lax. There is also no requirement for police and prosecutors to cooperate across borders.

(Editing by Alastair Macdonald)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Caste Bias

Caste Bias

Bigoted teachers lead marginalised Indian school kids to drop out - HRW.  Full Article 

Ferry Tragedy

Ferry Tragedy

Divers feel with their hands for corpses in depths of S.Korean ferry.  Full Article 

Australia Determined

Australia Determined

Australia vows to keep searching to solve missing Malayasian plane mystery.  Full Article 

Guns and Gowns

Guns and Gowns

Film “The World Before Her” juxtaposes two faces of Indian woman.  Full Article 

Mobile Ads

Mobile Ads

Google extends reach into mobile apps with new ad feature.  Full Article 

Allegations Denied

Allegations Denied

Allegations of teen sex abuse by three Hollywood execs denied.  Full Article 

Rising Tensions

Rising Tensions

U.S. vows more sanctions on Russia unless tensions ease in Ukraine.  Full Article 

Need for Speed

Need for Speed

United must move fast with vital window looming.  Article 

Afghanistan Exit

Afghanistan Exit

Exclusive - U.S. force in Afghanistan may be cut to less than 10,000 troops  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage